SAMHSA announces $930 million funding opportunity
The Substance Abuse and Mental Health Services Administration (SAMHSA), an agency within the Department of Health and Human Services (HHS), is now accepting applications for $930 million in State Opioid Response Grants. SAMHSA will distribute funds to states and territories in support of their ongoing efforts to provide prevention, treatment and recovery support services to individuals with opioid use disorder.
The State Opioid Response Grants aim to address the opioid crisis by increasing access to evidence-based medication-assisted treatment, reducing unmet treatment need and reducing opioid-related overdose deaths.
“This large new grant program reflects President Trump’s deep commitment to fighting the opioid crisis, and will provide extra support for the hardest-hit states,” said HHS Secretary Alex Azar. “It demonstrates the emphasis we place on expanding access to treatment that works, especially medication-assisted treatment with appropriate social supports.”
The grants will be awarded to the states and territories using a formula specified in the funding announcement. Fifteen percent of the total funds will be set aside to provide extra support to states that have been hardest hit by the crisis. States and territories will use the grants to design plans and conduct activities across the spectrum of prevention, treatment, and recovery.
These prevention, treatment, and recovery activities represent a comprehensive response to the opioid crisis and include action at the federal, state and local levels. “The State Opioid Response Grants were designed to meet the specific needs of communities within each state and territory,” explained Assistant Secretary for Mental Health and Substance Use Dr. Elinore F. McCance-Katz. “The grants will expand capacity to provide much needed evidence-based care to people who haven’t yet been reached.”
Under President Trump, in April 2017, HHS unveiled a new five-point Opioid Strategy. The Strategy prioritizes efforts in five areas: 1) Improving access to prevention, treatment and recovery support services, including medication-assisted treatment; 2) Promoting the targeted availability and distribution of overdose-reversing drugs; 3) Strengthening public health data reporting and collection; 4) Supporting cutting-edge research on addiction and pain and 5) Advancing the practice of pain management. Over fiscal years 2017 and 2018, HHS will invest over $4 billion in opioid-specific funding, including funds to state and local governments as well as tribal, public, and nonprofit organizations to support treatment and recovery services, target availability of overdose-reversing drugs, train first responders and more.
For more information on how to apply, see https://www.samhsa.gov/grants/grant-announcements/ti-18-015.